This information was published on 2025-12-16T00:08:29 for IP Right Acceptance Published.
| Field | Value |
| (210) | 2567019 |
| (220) |
15 Jul 2025
|
| (511) (510) |
Class 5
pain relief preparations containing CBD; THC for medical purposes; dysmenorrhea treatment preparations; pharmaceutical preparations and substances for use in gynaecology; pain relief medication; anti-inflammatory preparations; medicated confectionery; dietary supplements; food supplements for medical purposes; herbal dietary supplements; nutraceuticals for medical purposes; medicinal preparations and substances; pharmaceutical preparations for the treatment of hormonal disorders; pharmaceutical lozenges; pharmaceutical preparations and substances; capsules for medicines; drug delivery agents in the form of capsules that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; cannabis for medical purposes; medical cannabis in the form of capsules that facilitate the delivery of drugs; medical cannabis in the form of lozenges that facilitate the delivery of drugs; tetrahydrocannabidinol [THC] for medical purposes; cannabidiol for medical purposes; synthetic cannabinoids for medical purposes; menstrual symptom treatment preparations; nutraceuticals for therapeutic purposes; therapeutic drugs and agents; analgesic preparations; chemical preparations for therapeutic purposes |
| (540) | DYSPRO |
| (550) | Word |
| (730) |
EVE Health Group Limited
ACN/ABN 106523611 |
| (750) |
Farr Intellectual Property
|
Find out more about publications on the About page.